International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Virulence factors and protein secreted by S. aureus to protect itself from the host’s immune system

Takele Worku, Ebisa Mezgebu, Abdallah Bulbula

Animal Health Institute, Sebeta, Ethiopia

Article Information

Volume / Issue4 / 3 (July-September 2023)
Pages27-33
AccessOpen Access

Publication Timeline

  • Received15 July 2023
  • Accepted10 August 2023

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

The most harmful of the numerous common staphylococcal bacteria is Staphylococcus aureus, a gram-positive organism that causes a wide range of clinical diseases, including skin infections, bacteremia, endocarditis, pneumonia, and food poisoning. A variety of S. aureus virulence factors help to establish infection by encouraging tissue attachment, tissue invasion, and invasion of the host immune response. S. aureus is a pathogenic bacteria that, although being a commensal in both humans and animals, has the ability to produce several toxic and enzymes that allow it to penetrate the host  body and cause a variety of infections, some of which may be regarded as life-threatening diseases. Virulence factors provide mechanisms for bacterial growth support and disease-causing processes. Numerous virulence traits that S. aureus possesses enable it to success as a pathogen. Additionally through the secretion of proteins, S. aureus can activate host zymogens, which in turn can target certain defense components. Secreted proteins can also prevent neutrophils or the complement system's proteases from destroying pathogens, which raises the possibility that S. aurous will survive. The review aims to highlight S. aureus virulence factors and secretion protein that help the bacteria to survive from host immune system.

 

Keywords

Virulence factorsstaphylococcus aureusimmune evasionss. aureus secretion proteins

References

  1. Argudín MÁ, Mendoza MC, Rodicio MR. Food poisoning and Staphylococcus aureus enterotoxins. Toxins. 2010; 2(7):1751-1773. [Google Scholar][Crossref]
  2. Balaban N, Rasooly A. Staphylococcal enterotoxins. International journal of food microbiology. 2000; 61(1):1-10. [Google Scholar][Crossref]
  3. Bokarewa MI, Jin T, Tarkowski A. Staphylococcus aureus: staphylokinase. The international journal of biochemistry & cell biology. 2006; 38(4):504-509. [Google Scholar][Crossref]
  4. Bonar E, Międzobrodzki J, Władyka B. The staphylococcal coagulases. In Pet-To-Man Travelling Staphylococci, 2018, 95-102. [Google Scholar][Crossref]
  5. Costa SS, Ribeiro R, Serrano M, Oliveira K, Ferreira C, Leal M, et al. Staphylococcus aureus causing skin and soft tissue infections in companion animals: Antimicrobial resistance profiles and clonal lineages. Antibiotics. 2022; 11(5):599. [Google Scholar][Crossref]
  6. De Jong NW, Van Kessel KP, Van Strijp JA. Immune evasion by Staphylococcus aureus. Microbiology spectrum. 2019; 7(2):7-2. [Google Scholar][Crossref]
  7. Dezfulian A, Salehian MT, Amini V, Dabiri H, Azimirad M, Aslani MM, et al. Catalase-negative Staphylococcus aureus isolated from a diabetic foot ulcer. Iranian Journal of Microbiology. 2010; 2(3):165. [Google Scholar][Crossref]
  8. Dufrêne YF, Viljoen A. Binding strength of Gram-positive bacterial adhesins. Frontiers in microbiology. 2020; 11:1457. [Google Scholar][Crossref]
  9. Eisenbeis J, Saffarzadeh M, Peisker H, Jung P, Thewes N, Preissner KT, et al. The Staphylococcus aureus extracellular adherence protein Eap is a DNA binding protein capable of blocking neutrophil extracellular trap formation. Frontiers in cellular and infection microbiology. 2018; 8:235. [Google Scholar][Crossref]
  10. Francis D, Bhairaddy A, Joy A, Hari GV, Francis A. Secretory proteins in the orchestration of microbial virulence: The curious case of Staphylococcus aureus. Adv. Protein Chem. Struct. Biol. 2023; 133:271-350. [Google Scholar][Crossref]
  11. Gnanamani A, Hariharan P, Paul-Satyaseela M. Staphylococcus aureus: Overview of bacteriology, clinical diseases, epidemiology, antibiotic resistance and therapeutic approach. Frontiers in Staphylococcus aureus. 2017; 4(28):10-5772. [Google Scholar][Crossref]
  12. Haggar A, Flock JI, Norrby-Teglund A. Extracellular International Journal of Medical and All Body Health Research www.allmedicaljournal.com adherence protein (Eap) from Staphylococcus aureus does not function as a superantigen. Clinical microbiology and infection. 2010; 16(8):1155-1158. [Google Scholar][Crossref]
  13. Hart ME, Hart MJ, Roop AJ. Genotypic and phenotypic assessment of hyaluronidase among type strains of a select group of staphylococcal species. International Journal of Microbiology, 2009. [Google Scholar][Crossref]
  14. Hu C, Xiong N, Zhang Y, Rayner S, Chen S. Functional characterization of lipase in the pathogenesis of Staphylococcus aureus. Biochemical and biophysical research communications. 2012; 419(4):617-620. [Google Scholar][Crossref]
  15. Hynes WL, Walton SL. Hyaluronidases of Gram-positive bacteria. FEMS microbiology letters. 2000; 183(2):201-207. [Google Scholar][Crossref]
  16. Ibberson CB, Jones CL, Singh S, Wise MC, Hart ME, Zurawski DV, et al. Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor. Infection and immunity. 2014; 82(10):4253-4264. [Google Scholar][Crossref]
  17. Ilie MI, Marandiuc IM, Velescu BȘ, Udeanu DI, Arsene AL. Staphylococcus aureus toxicity, 2023. [Google Scholar][Crossref]
  18. Jooste PJ, Anelich L, Motarjemi Y. Safety of food and beverages: milk and dairy products, 2014. [Google Scholar][Crossref]
  19. Ko YP, Kang M, Ganesh VK, Ravirajan D, Li B, Höök M. Coagulase and Efb of Staphylococcus aureus have a common fibrinogen binding motif. MBio. 2016; 7(1):e01885-15. [Google Scholar][Crossref]
  20. Kong C, Neoh HM, Nathan S. Targeting Staphylococcus aureus toxins: a potential form of anti-virulence therapy. Toxins. 2016; 8(3):72. [Google Scholar][Crossref]
  21. Kranjec C, Morales Angeles D, Torrissen Mårli M, Fernández L, García P, Kjos M, et al. Staphylococcal biofilms: Challenges and novel therapeutic perspectives. Antibiotics. 2021; 10(2):131. [Google Scholar][Crossref]
  22. Kwiecinski J, Peetermans M, Liesenborghs L, Na M, Björnsdottir H, Zhu X, et al. Staphylokinase control of Staphylococcus aureus biofilm formation and detachment through host plasminogen activation. The Journal of infectious diseases. 2016; 213(1):139-148. [Google Scholar][Crossref]
  23. Laarman A, Milder F, van Strijp J, Rooijakkers S. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. Journal of molecular medicine. 2010; 88:115-120. [Google Scholar][Crossref]
  24. Le Loir Y, Hennekinne JA. Detection of staphylococcal enterotoxins, 2014. [Google Scholar][Crossref]
  25. Liu D. Enterotoxin-producing Staphylococcus aureus. In Molecular Medical Microbiology. Academic Press, 2015, 979-995. [Google Scholar][Crossref]
  26. Malak HA, Abulreesh HH, Organji SR, Elbanna K, Shaaban MR, Ahmad I, et al. Immune system evasion mechanisms in Staphylococcus aureus: current understanding. J Pure Appl Microbiol. 2020; 14(4):2219-2234. [Google Scholar][Crossref]
  27. Mandell GL. Catalase, superoxide dismutase, and virulence of Staphylococcus aureus. In vitro and in vivo studies with emphasis on staphylococcal--leukocyte interaction. The Journal of clinical investigation. 1975; 55(3):561-566. [Google Scholar][Crossref]
  28. McAdow M, Missiakas DM , Schneewind O. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. Journal of innate immunity. 2012; 4(2):141-148. [Google Scholar][Crossref]
  29. Mohamed N, Timofeyeva Y, Jamrozy D, Rojas E, Hao L, Silmon de Monerri NC, et al. Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States. PloS one. 2019; 14(1):e0208356. [Google Scholar][Crossref]
  30. Nanra JS, Buitrago SM, Crawford S, Ng J, Fink PS, Hawkins J, et al. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Human vaccines & immunotherapeutics. 2013; 9(3), 480-487. [Google Scholar][Crossref]
  31. Nguyen LT, Vogel HJ. Staphylokinase has distinct modes of interaction with antimicrobial peptides, modulating its plasminogen-activation properties. Scientific reports. 2016; 6(1):31817. [Google Scholar][Crossref]
  32. O'Riordan K, Lee JC. Staphylococcus aureus capsular polysaccharides. Clinical microbiology reviews. 2004; 17(1):218-234. [Google Scholar][Crossref]
  33. Ortega E, Abriouel H, Lucas R, Gálvez A. Multiple roles of Staphylococcus aureus enterotoxins: pathogenicity, superantigenic activity, and correlation to antibiotic resistance. Toxins. 2010; 2(8):2117-2131. [Google Scholar][Crossref]
  34. Pietrocola G, Nobile G, Rindi S, Speziale P. Staphylococcus aureus manipulates innate immunity through own and host-expressed proteases. Frontiers in cellular and infection microbiology. 2017; 7:166. [Google Scholar][Crossref]
  35. Peschel A, Collins LV. Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides. 2001; 22(10):1651-1659. [Google Scholar][Crossref]
  36. Reyes-Robles T, Alonzo F, Kozhaya L, Lacy DB, Unutmaz D, Torres VJ. Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell host & microbe. 2013; 14(4):453-459. [Google Scholar][Crossref]
  37. Schwarz S, Fessler AT, Loncaric I, Wu C, Kadlec K, Wang Yand, et al. Antimicrobial resistance among staphylococci of animal origin. Microbiology spectrum. 2018; 6(4):6-4. [Google Scholar][Crossref]
  38. Silva-de-Jesus AC, Ferrari RG, Panzenhagen P, Conte-Junior CA. Staphylococcus aureus biofilm: the role in disseminating antimicrobial resistance over the meat chain. Microbiology. 2022; 168(10):001. [Google Scholar][Crossref]
  39. Ferguson AJ. Staphylococcal toxic shock syndrome: mechanisms and management. Current infectious disease reports. 2010; 12:392-400. [Google Scholar][Crossref]
  40. Skalka B. Hyaluronidase test in the diagnosis of staphylococci. Veterinarni Medicina. 1985; 30(6):373-378. [Google Scholar][Crossref]
  41. Soufer D. Protecting penicillin from penicillinase. Microbios. 1986; 45(184-185):193-198. [Google Scholar][Crossref]
  42. Van Kessel KP, Prossnitz R, van Strijp JA, de Haas CJ. Chemotaxis Inhibitory Protein of. J Immunol. 2004; 172:6994-7001. [Google Scholar][Crossref]
  43. Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors?. Frontiers in cellular and infection microbiology. 2012; 2:12. [Google Scholar][Crossref]
  44. Walev I, Weller U, Strauch S, Foster T, Bhakdi S. Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Infection and immunity. 1996; 64(8):2974-2979. [Google Scholar][Crossref]
  45. Wilke GA, Wardenburg JB. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin–mediated cellular injury. Proceedings of the National Academy of Sciences. 2010; 107(30):13473-International Journal of Medical and All Body Health Research www.allmedicaljournal.com 13478. [Google Scholar][Crossref]
  46. Yoong P, Torres VJ. The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Current opinion in microbiology. 2013; 16(1):63-69. [Google Scholar][Crossref]
  47. Zhang X, Xiong T, Gao L, Wang Y, Liu L, Tian T, et al. Extracellular fibrinogen-binding protein released by intracellular Staphylococcus aureus suppresses host immunity by targeting TRAF3. Nature Communications. 2022; 13(1):5493. [Google Scholar][Crossref]
  48. Kudryashova E, Seveau SM, Kudryashov DS. Targeting and inactivation of bacterial toxins by human defensins. Biological chemistry. 2017; 398(10):1069-1085. [Google Scholar][Crossref]

How to Cite

Worku, T., Mezgebu, E., & Bulbula, A. (2023). Virulence factors and protein secreted by S. aureus to protect itself from the host’s immune system. International Journal of Medical and All Body Health Research, 4(3), 27-33.

Worku, Takele, et al. "Virulence factors and protein secreted by S. aureus to protect itself from the host’s immune system." International Journal of Medical and All Body Health Research, vol. 4, no. 3, 2023, pp. 27-33.

Worku, T., Mezgebu, E. and Bulbula, A. (2023) 'Virulence factors and protein secreted by S. aureus to protect itself from the host’s immune system', International Journal of Medical and All Body Health Research, 4(3), pp. 27-33.

Worku T, Mezgebu E, Bulbula A. Virulence factors and protein secreted by S. aureus to protect itself from the host’s immune system. International Journal of Medical and All Body Health Research. 2023;4(3):27-33.

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex ResearchGate BASE

A newly published article may take a few days to appear on these services.